Conference Coverage ACC 2018 See All Content See past conferences Orlando, FL March 10, 2018 March 12, 2018 News Conference News My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up Are clinical trials in cardiology doing any better at enrolling women? Minorities? Nanette Kass Wenger thinks this is an idea whose time has come. < > ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018 Mixing Haircuts and Hypertension Rx a ‘Home Run’ for Blood Pressure Control Todd Neale March 12, 2018 Wearable Cardioverter-Defibrillator Fails to Meet Primary Endpoint in First Randomized Trial Todd Neale March 10, 2018 Apixaban Has Edge Over Other NOACs in Large, Real-World Analysis Todd Neale March 12, 2018 Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS Caitlin E. Cox March 11, 2018 NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients Shelley Wood March 10, 2018 MANAGE Suggests Dabigatran Could Be Useful for Treating Myocardial Injury After Noncardiac Surgery Todd Neale March 11, 2018 TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis Shelley Wood March 11, 2018 COMPASS Approach Helps With Leg Complications in Patients With PAD Todd Neale March 12, 2018 Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis Michael O'Riordan March 01, 2018 Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease Yael L. Maxwell March 09, 2018 Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery Yael L. Maxwell March 10, 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018 News News Conference News PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats Yael L. Maxwell March 14, 2018 News Conference News Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4 Yael L. Maxwell March 19, 2018 News Conference News Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial Caitlin E. Cox March 14, 2018 News Conference News Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4 Todd Neale March 13, 2018 News Conference News Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial Yael L. Maxwell March 12, 2018 News Conference News Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues Michael O'Riordan March 11, 2018 Slides Presentation The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome Presenter: Philippe Gabriel Steg March 10, 2018 Presentation CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes Presenter: Brendan M. Everett March 12, 2018 Presentation ARTEMIS: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Presenter: Tracy Wang March 12, 2018 Presentation MANAGE: Dabigatran in Myocardial Injury After Noncardiac Surgery Presenter: Philip Devereaux March 12, 2018 Presentation Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study Presenter: Ajay J. Kirtane March 11, 2018 Yael L. Maxwell Interviews Dr. Jacqueline Tamis-Holland See More Videos Live Blog News Conference News ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More Shelley Wood March 12, 2018 News Conference News ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More Shelley Wood March 11, 2018 News Conference News ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins Shelley Wood March 10, 2018
News Conference News My Takeaways From ACC 2018: Everyone Missing From Clinical Trials, Please Stand Up Are clinical trials in cardiology doing any better at enrolling women? Minorities? Nanette Kass Wenger thinks this is an idea whose time has come.
ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018
Mixing Haircuts and Hypertension Rx a ‘Home Run’ for Blood Pressure Control Todd Neale March 12, 2018
Wearable Cardioverter-Defibrillator Fails to Meet Primary Endpoint in First Randomized Trial Todd Neale March 10, 2018
Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS Caitlin E. Cox March 11, 2018
MANAGE Suggests Dabigatran Could Be Useful for Treating Myocardial Injury After Noncardiac Surgery Todd Neale March 11, 2018
TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis Shelley Wood March 11, 2018
Flu Vaccine Reduces Mortality, Hospitalization in HF Patients: Meta-analysis Michael O'Riordan March 01, 2018
Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease Yael L. Maxwell March 09, 2018
Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery Yael L. Maxwell March 10, 2018
ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats Yael L. Maxwell March 14, 2018
News Conference News Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4 Yael L. Maxwell March 19, 2018
News Conference News Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial Caitlin E. Cox March 14, 2018
News Conference News Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4 Todd Neale March 13, 2018
News Conference News Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial Yael L. Maxwell March 12, 2018
News Conference News Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues Michael O'Riordan March 11, 2018
Presentation The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome Presenter: Philippe Gabriel Steg March 10, 2018
Presentation CANTOS: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes Presenter: Brendan M. Everett March 12, 2018
Presentation ARTEMIS: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Presenter: Tracy Wang March 12, 2018
Presentation MANAGE: Dabigatran in Myocardial Injury After Noncardiac Surgery Presenter: Philip Devereaux March 12, 2018
Presentation Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study Presenter: Ajay J. Kirtane March 11, 2018
News Conference News ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More Shelley Wood March 12, 2018
News Conference News ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More Shelley Wood March 11, 2018
News Conference News ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins Shelley Wood March 10, 2018